Fathom Therapeutics
PrivateLast Round
Series A
Apr 27, 2026
Total Funding Raised
$54.08M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Fathom Therapeutics is a biotechnology company that uses physics-based simulations and AI to model protein motion and interactions at atomic resolution for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fathom Therapeutics Comparables
Compare Fathom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PsiThera | 90% | |
| Iambic Therapeutics | 86% | |
| TandemAI | 85% | |
Fathom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 27, 2026 | ||||
| Early Stage VC | Mar 20, 2026 | ||||
| Seed | Nov 16, 2023 |
Key People
Founding team and executive leadership
Fathom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemistry VC | Series A |
| Alexandria Venture Investments | Series A |
| New York Ventures | Series A |
| Sutter Hill Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jun 19, 2026
Monthly visitors increased 81% MoM.
Fathom Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fathom Therapeutics's valuation, stock price, and market status.